Expression and prognostic relevance of p21 WAF1 in stage III esophageal squamous cell carcinoma

Diseases of the Esophagus

Volumn 25, Issue 1, 2012, Pages 67-71

  Liu, J ^a   Hu, Y ^a   Hu, W ^b   Xie, X ^a   Ela Bella, A ^a   Fu, J ^a   Rao, D ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Esophageal neoplasm; Immunohistochemistry; Lymph node metastasis; P21 WAF1; Prognosis

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84855787094     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2011.01217.x     Document Type: Article

References (31)

1. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 1995; 82: 675-84.
2. Brugarolas J, Chandrasekaran C, Gordon J I, Beach D, Jacks T, Hannon G J. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 1995; 377: 552-7.
3. Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 2009; 9: 400-14.
4. Waf1/Cip1/Sdi1: association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett 2002; 179: 1-14.
5. Gartel A L. Is p21 an oncogene? Mol Cancer Ther 2006; 5: 1385-6.
6. Lin D C, Shi Z Z, Xue L Y etal. Expression of cell cycle related proteins cyclin D1, p53 and p21WAF1/Cip1 in esophageal squamous cell carcinoma. Yi Chuan 2010; 32: 455-60.
7. WAF1 predicts outcome of esophageal cancer patients treated by surgery alone or by combined therapy modalities. Clin Cancer Res 1998; 4: 2615-23.
8. Goan Y G, Hsu H K, Chang H C, Chou Y P, Chiang K H, Cheng J T. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients. Ann Thorac Surg 2005; 80: 1007-16.
9. Zhu Z-H, Sun B-Y, Ma Y etal. Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small-cell lung cancer. J Clin Oncol 2009; 27: 1091-9.
10. Watanabe M, Kuwano H, Tanaka S, Toh Y, Sadanaga N, Sugimachi K. Flow cytometric DNA analysis is useful in detecting multiple genetic alterations in squamous cell carcinoma of the esophagus. Cancer 1999; 85: 2322-8.
11. LaBaer J, Garrett M D, Stevenson L F etal. New functional activities for the p21 family of CDK inhibitors. Genes Dev 1997; 11: 847-62.
12. Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc Natl Acad Sci USA 2000; 97: 4291-6.
13. Ogino S, Kawasaki T, Kirkner G J etal. Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer. J Pathol 2006; 210: 147-54.
14. WAF1/CIP1 are associated with metastasis in colorectal carcinomas. Hepatogastroenterology 2005; 52: 1421-6.
15. Cip1/WAF1 expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosis. Mod Pathol 2009; 22: 686-98.
16. Aoyagi K, Koufuji K, Yano S etal. The expression of p53, p21 and TGF beta 1 in gastric carcinoma. Kurume Med J 2003; 50: 1-7.
17. Ogawa M, Onoda N, Maeda K etal. A combination analysis of p53 and p21 in gastric carcinoma as a strong indicator for prognosis. Int J Mol Med 2001; 7: 479-83.
18. WAF1/CIP1 is an early event in the development of pancreatic intraepithelial neoplasia. Cancer Res 2001; 61: 8830-7.
19. Kapranos N, Stathopoulos G P, Manolopoulos L etal. p53, p21 and p27 protein expression in head and neck cancer and their prognostic value. Anticancer Res 2001; 21: 521-8.
20. CIP1/WAF1 is correlated with IKKβ overexpression in human breast cancers. Int J Oncol 2006; 29: 1103-10.
21. WAF1/CIP1 expression in human hepatocellular carcinomas. Liver Int 2006; 26: 1018-9.
22. Waf1/Cip1 immunolocalization in multiple myeloma. Biomed Res 2005; 26: 91-8.
23. waf1/cip1 protein in prostate cancer. Prostate 1999; 39: 8-15.
24. Bae D S, Cho S B, Kim Y J etal. Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus. Gynecol Oncol 2001; 81: 341-7.
25. WAF1/CIP1 protein expression in primary ovarian cancer. Int J Oncol 2000; 17: 1231-5.
26. Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol 2001; 3: 245-52.
27. WAF1/CIP1 expression is correlated with HER-2/neu in breast cancer and is an independent predictor of prognosis. Breast Cancer Res 2003; 5: 242-9.
28. WAF1/Cip1 functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential. Proc Natl Acad Sci USA 1999; 96: 9089-94.
29. Kippin T E, Martens D J, van der Kooy D. p21 loss compromises the relative quiescence of forebrain stem cell proliferation leading to exhaustion of their proliferation capacity. Genes Dev 2005; 19: 756-67.
30. WAF1/Cip1 on apoptosis and sensitivity to cancer chemotherapy. Drug Resist Updat 2003; 6: 183-95.
31. Tanaka Y, Fujii T, Yamana H, Kato S, Morimatsu M, Shirouzu K. Experimental gene therapy using p21Waf1 gene for esophageal squamous cell carcinoma by gene gun technology. Int J Mol Med 2004; 14: 545-51.